In this issue:
InO salvage plus allo-HSCT shows clinical benefit for RR ALL
Tandem vs single ASCT for high-risk neuroblastoma
Faecal microbiota transplantation is feasible in immunocompromised patients also undergoing allo-HSCT
Intense conditioning with FBT prior to haplo-SCT is effective for AML patients with low-disease status
Vitamin D receptor SNPs determine the immunodulatory effect of vitamin D on GvHD after allo-HSCT
ASCT for elderly MM patients
Outpatient ASCT for paediatric patients with CNS tumours
Upfront transplant versus pre-transplant cytoreductive treatment for MDS and sAML
Consolidation ASCT for T-NHL
Please login below to download this issue (PDF)